Iron chelation in the biological activity of curcumin

Free Radical Biology and Medicine

Volumn 40, Issue 7, 2006, Pages 1152-1160

  Jiao, Yan ^a   Wilkinson IV, John ^a   Christine Pietsch, E ^a   Buss, Joan L ^a   Wang, Wei ^a   Planalp, Roy ^b   Torti, Frank M ^a   Torti, Suzy V ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b Univ of New Hampshire   (United States)

Author keywords

Chelator; Chemoprevention; Curcumin; Ferritin; Free radicals; Glutathione S transferase; Iron

Indexed keywords

CD71 ANTIGEN; CURCUMIN; FERRITIN; GLUTATHIONE TRANSFERASE; IRON CHELATING AGENT; IRON REGULATORY FACTOR; LIVER PROTEIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG EFFECT; FEMALE; IN VIVO STUDY; IRON BINDING CAPACITY; IRON CHELATION; IRON DEPLETION; IRON METABOLISM; IRON RESPONSIVE ELEMENT; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; CURCUMIN; DIET; FEMALE; FERRITINS; GLUTATHIONE TRANSFERASE; IRON; IRON CHELATING AGENTS; IRON REGULATORY PROTEIN 1; LIVER; MICE; RECEPTORS, TRANSFERRIN;

ANIMALIA;

EID: 33644988713     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.11.003     Document Type: Article

References (48)

1. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
2. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
3. R. Srivastava, and R.C. Srimal Modification of certain inflammation-induced biochemical changes by curcumin Indian J. Med. Res. 81 1985 215 223
4. A.J. Ruby, G. Kuttan, K.D. Babu, K.N. Rajasekharan, and R. Kuttan Anti-tumour and antioxidant activity of natural curcuminoids Cancer Lett. 94 1995 79 83
5. C.J. Li, L.J. Zhang, B.J. Dezube, C.S. Crumpacker, and A.B. Pardee Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication Proc. Natl. Acad. Sci. USA 90 1993 1839 1842
6. R.A. Sharma, C.R. Ireson, R.D. Verschoyle, K.A. Hill, M.L. Williams, C. Leuratti, M.M. Manson, L.J. Marnett, W.P. Steward, and A. Gescher Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels Clin. Cancer Res. 7 2001 1452 1458
7. G.J. Kelloff, J.A. Crowell, E.T. Hawk, V.E. Steele, R.A. Lubet, C.W. Boone, J.M. Covey, L.A. Doody, G.S. Omenn, P. Greenwald, W.K. Hong, D.R. Parkinson, D. Bagheri, G.T. Baxter, M. Blunden, M.K. Doeltz, K.M. Eisenhauer, K. Johnson, G.G. Knapp, D.G. Longfellow, W.F. Malone, S.G. Nayfield, H.E. Seifried, L.M. Swall, and C.C. Sigman Strategy and planning for chemopreventive drug development: clinical development plans II J. Cell. Biochem. Suppl. 26 1996 54 71
8. A.L. Cheng, C.H. Hsu, J.K. Lin, M.M. Hsu, Y.F. Ho, T.S. Shen, J.Y. Ko, J.T. Lin, B.R. Lin, W. Ming-Shiang, H.S. Yu, S.H. Jee, G.S. Chen, T.M. Chen, C.A. Chen, M.K. Lai, Y.S. Pu, M.H. Pan, Y.J. Wang, C.C. Tsai, and C.Y. Hsieh Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res. 21 2001 2895 2900
9. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, H.R. Hewitt, T.H. Marczylo, B. Morgan, D. Hemingway, S.M. Plummer, M. Pirmohamed, A.J. Gescher, and W.P. Steward Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin. Cancer Res. 10 2004 6847 6854
10. N.R. Jana, P. Dikshit, A. Goswami, and N. Nukina Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway J. Biol. Chem. 279 2004 11680 11685
11. S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, S. Farrow, and L. Howells Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex Oncogene 18 1999 6013 6020
12. C. Jobin, C.A. Bradham, M.P. Russo, B. Juma, A.S. Narula, D.A. Brenner, and R.B. Sartor Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity J. Immunol. 163 1999 3474 3483
13. D. Deeb, H. Jiang, X. Gao, M.S. Hafner, H. Wong, G. Divine, R.A. Chapman, S.A. Dulchavsky, and S.C. Gautam Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation Mol. Cancer Ther. 3 2004 803 812
14. S. Aggarwal, Y. Takada, S. Singh, J.N. Myers, and B.B. Aggarwal Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling Int. J. Cancer 111 2004 679 692
15. D.A. Dickinson, K.E. Iles, H. Zhang, V. Blank, and H.J. Forman Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression FASEB J. 17 2003 473 475
16. J.H. Woo, Y.H. Kim, Y.J. Choi, D.G. Kim, K.S. Lee, J.H. Bae, S. Min do, J.S. Chang, Y.J. Jeong, Y.H. Lee, J.W. Park, and T.K. Kwon Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 24 2003 1199 1208
17. J.T. Piper, S.S. Singhal, M.S. Salameh, R.T. Torman, Y.C. Awasthi, and S. Awasthi Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver Int. J. Biochem. Cell. Biol. 30 1998 445 456
18. E. Balogun, M. Hoque, P. Gong, E. Killeen, C.J. Green, R. Foresti, J. Alam, and R. Motterlini Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element Biochem. J. 371 2003 887 895
19. A.T. Dinkova-Kostova, and P. Talalay Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes Carcinogenesis 20 1999 911 914
20. S. Fujisawa, T. Atsumi, M. Ishihara, and Y. Kadoma Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds Anticancer Res. 24 2004 563 569
21. J. Fang, J. Lu, and A. Holmgren Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity J. Biol. Chem. 2005
22. M. Bernabe-Pineda, M.T. Ramirez-Silva, M.A. Romero-Romo, E. Gonzalez-Vergara, and A. Rojas-Hernandez Spectrophotometric and electrochemical determination of the formation constants of the complexes curcumin-Fe(III)-water and curcumin-Fe(II)-water Spectrochim. Acta A Mol. Biomol. Spectrosc. 60 2004 1105 1113
23. E.C. Pietsch, J.Y. Chan, F.M. Torti, and S.V. Torti Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones J. Biol. Chem. 278 2003 2361 2369
24. F.M. Torti, and S.V. Torti Regulation of ferritin genes and protein Blood 99 2002 3505 3516
25. E.C. Theil The iron responsive element (IRE) family of mRNA regulators. Regulation of iron transport and uptake compared in animals, plants, and microorganisms Met. Ions Biol. Syst. 35 1998 403 434
26. P. Ponka Cellular iron metabolism Kidney Int. Suppl. 69 1999 S2 S11
27. M.W. Hentze, M.U. Muckenthaler, and N.C. Andrews Balancing acts: molecular control of mammalian iron metabolism Cell 117 2004 285 297
28. R.S. Eisenstein Iron regulatory proteins and the molecular control of mammalian iron metabolism Annu. Rev. Nutr. 20 2000 627 662
29. E.C. Pietsch, A.L. Hurley, E.E. Scott, B.P. Duckworth, M.E. Welker, S. Leone-Kabler, A.J. Townsend, F.M. Torti, and S.V. Torti Oxathiolene oxides: a novel family of compounds that induce ferritin, glutathione S-transferase, and other proteins of the phase II response Biochem. Pharmacol. 65 2003 1261 1269
30. J.t. Wilkinson, V. Radjendirane, G.R. Pfeiffer, A.K. Jaiswal, and M.L. Clapper Disruption of c-Fos leads to increased expression of NAD(P)H:quinone oxidoreductase1 and glutathione S-transferase Biochem. Biophys. Res. Commun. 253 1998 855 858
31. L.W. Wattenberg An overview of chemoprevention: current status and future prospects Proc. Soc. Exp. Biol. Med. 216 1997 133 141
32. K. Pantopoulos Iron metabolism and the IRE/IRP regulatory system: an update Ann. N.Y. Acad. Sci. 1012 2004 1 13
33. S.E. Chuang, M.L. Kuo, C.H. Hsu, C.R. Chen, J.K. Lin, G.M. Lai, C.Y. Hsieh, and A.L. Cheng Curcumin-containing diet inhibits diethylnitrosamine- induced murine hepatocarcinogenesis Carcinogenesis 21 2000 331 335
34. J. Ushida, S. Sugie, K. Kawabata, Q.V. Pham, T. Tanaka, K. Fujii, H. Takeuchi, Y. Ito, and H. Mori Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats Jpn. J. Cancer Res. 91 2000 893 898
35. T. Kawamori, R. Lubet, V.E. Steele, G.J. Kelloff, R.B. Kaskey, C.V. Rao, and B.S. Reddy Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res. 59 1999 597 601
36. M.T. Huang, H.L. Newmark, and K. Frenkel Inhibitory effects of curcumin on tumorigenesis in mice J. Cell. Biochem. Suppl. 27 1997 26 34
37. N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa) J. Altern. Complement Med. 9 2003 161 168
38. T. Primiano, T.W. Kensler, P. Kuppusamy, J.L. Zweier, and T.R. Sutter Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones Carcinogenesis 17 1996 2291 2296
39. K. Nakano, T. Nakayachi, E. Yasumoto, S.R. Morshed, K. Hashimoto, H. Kikuchi, H. Nishikawa, K. Sugiyama, O. Amano, M. Kawase, and H. Sakagami Induction of apoptosis by beta-diketones in human tumor cells Anticancer Res. 24 2004 711 717
40. C. Ireson, S. Orr, D.J. Jones, R. Verschoyle, C.K. Lim, J.L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, W.P. Steward, and A. Gescher Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production Cancer Res. 61 2001 1058 1064
41. G.M. Holder, J.L. Plummer, and A.J. Ryan The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat Xenobiotica 8 1978 761 768
42. B. Wahlstrom, and G. Blennow A study on the fate of curcumin in the rat Acta Pharmacol. Toxicol. (Copenh) 43 1978 86 92
43. A.E. Martell R.M. Smith Critical Stability Constants 1977 Plenum Press New York
44. J.L. Buss, F.M. Torti, and S.V. Torti The role of iron chelation in cancer therapy Curr. Med. Chem. 10 2003 1021 1034
45. S.Y. Qian, and G.R. Buettner Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: an electron paramagnetic resonance spin trapping study Free Radic. Biol. Med. 26 1999 1447 1456
46. R.S. Britton, K.L. Leicester, and B.R. Bacon Iron toxicity and chelation therapy Int. J. Hematol. 76 2002 219 228
47. J. Emerit, C. Beaumont, and F. Trivin Iron metabolism, free radicals, and oxidative injury Biomed. Pharmacother. 55 2001 333 339
48. M.B. Sporn, and N. Suh Chemoprevention: an essential approach to controlling cancer Nat. Rev. Cancer 2 2002 537 543